The MediShield Life Council has announced a comprehensive review of Singapore’s basic, mandatory health insurance plan. The review would look at expanding the coverage of MediShield Life, including funding for innovative treatments such as cell, tissue and gene therapy products (CTGTP).
What principles should guide this and future healthcare policies?
Hear from Assoc Prof Jeremy Lim as he highlights the importance of incentivising outpatient treatment and the potential of personalised medicine to save lives.